Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Oncolytic Viruses Partner With T-Cell Therapy for Solid Tumor Treatment.

Rosewell Shaw A, Suzuki M.

Front Immunol. 2018 Sep 21;9:2103. doi: 10.3389/fimmu.2018.02103. eCollection 2018. Review.

2.

Adenovirotherapy Delivering Cytokine and Checkpoint Inhibitor Augments CAR T Cells against Metastatic Head and Neck Cancer.

Rosewell Shaw A, Porter CE, Watanabe N, Tanoue K, Sikora A, Gottschalk S, Brenner MK, Suzuki M.

Mol Ther. 2017 Nov 1;25(11):2440-2451. doi: 10.1016/j.ymthe.2017.09.010. Epub 2017 Sep 14.

3.

Armed Oncolytic Adenovirus-Expressing PD-L1 Mini-Body Enhances Antitumor Effects of Chimeric Antigen Receptor T Cells in Solid Tumors.

Tanoue K, Rosewell Shaw A, Watanabe N, Porter C, Rana B, Gottschalk S, Brenner M, Suzuki M.

Cancer Res. 2017 Apr 15;77(8):2040-2051. doi: 10.1158/0008-5472.CAN-16-1577. Epub 2017 Feb 24.

4.

Recent advances in oncolytic adenovirus therapies for cancer.

Rosewell Shaw A, Suzuki M.

Curr Opin Virol. 2016 Dec;21:9-15. doi: 10.1016/j.coviro.2016.06.009. Epub 2016 Jul 2. Review.

Supplemental Content

Loading ...
Support Center